New NIH fact sheet explains test for diabetes, prediabetes

January 27, 2012 By Mary Harris in Diabetes

A new fact sheet from the National Institutes of Health explains the A1C test, a widely used and important test to diagnose type 2 diabetes and prediabetes, and to monitor blood glucose levels of people with type 1 and type 2 diabetes.

The A1C blood test provides information about average blood glucose levels, also called , over the past three months. The test is sometimes referred to as the , , or glycohemoglobin test. The test result is reported as a percentage. The higher the percentage, the higher a person's average blood glucose levels, which can cause complications in people with diabetes. A normal A1C level is below 5.7 percent.

"The fact sheet, called The A1C Test and Diabetes, offers in-depth information for people being tested," said Judith Fradkin, M.D., a diabetes specialist at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). "Lab tests and results, particularly the A1C, can be confusing. We hope this fact sheet will help people better understand why the test is important, how to interpret results, and why results may differ from expected."

The A1C Test and Diabetes covers a wide range of information, including

• how the test works
• other blood tests for type 2 diabetes and prediabetes
• accuracy of blood tests
• where to learn more about A1C tests in people with hemoglobin variants
• A1C targets

Originally, the A1C test had been recommended only for monitoring diabetes. But in 2009, an international committee of experts convened by the American Diabetes Association, International Diabetes Federation and European Association for the Study of Diabetes recommended expanding the use of the test to include diagnosing type 2 diabetes and prediabetes. The test is convenient because it does not require fasting.

Experts hope the ease of A1C testing will encourage more people to be checked for prediabetes and type 2 diabetes. Early identification and prompt treatment can delay or prevent type 2 diabetes and complications of the disease. The A1C test also helps providers adjust medication for people with diabetes to reduce the risk of long-term complications.

About 26 million Americans are living with diabetes, and more than 7 million of them do not know it. Left untreated, diabetes can lead to heart disease, stroke, kidney disease, blindness, amputation, and other serious complications. An estimated 79 million adults have prediabetes, that are higher than normal but not high enough to be called diabetes, which places people at increased risk for developing type 2 diabetes. Weight loss and increased physical activity or the drug metformin can delay or prevent type 2 diabetes, but fewer than 10 percent of people with prediabetes have been diagnosed.

The standard blood glucose tests for diagnosing type 2 diabetes and prediabetes — the fasting plasma glucose test and the oral glucose tolerance test (OGTT) — measure blood glucose in a person who has not eaten anything for at least eight hours. The OGTT also measures blood glucose two hours after a person drinks a glucose-containing beverage. To confirm positive results, people should return on a different day to repeat the tests. The A1C test should also be repeated to confirm a diagnosis.

"Now people can be tested for diabetes without fasting," said David Sacks, Ph.D., chair of a group working to standardize lab testing for diabetes and a member of the NIH Clinical Center's Department of Laboratory Medicine. "We hope the convenience of the A1C test will encourage more people to be tested for and diabetes."

If you are at least 45 years old, or younger than 45 and are overweight, inactive, and have at least one risk factor for , consider being tested for the disease. Risk factors include high blood pressure; high cholesterol; a family history of diabetes; a history of gestational diabetes; and African-American, Hispanic-American, Asian-American, Pacific Islander or American Indian heritage.

A1C results can be unreliable in some people. For example, people of African, Mediterranean or Southeast Asian descent, or people who have a family member with sickle cell anemia, may not know that they have a less common type of hemoglobin that can interfere with some A1C tests. If you have a family history of sickle cell or thalassemia, or A1C results seem very different from those of a test, talk to your doctor about which A1C tests are appropriate for you.

The fact sheet, The A1C Test and Diabetes, is available from NIDDK's National Diabetes Information Clearinghouse at www..niddk.nih.gov/dm/pubs/A1CTest .

Provided by National Institutes of Health

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • slit width order of wavelength
    created3 hours ago
  • Non-Uniform Charge Distribution of a Metal Cone
    created7 hours ago
  • velocity from acceleration if acceleration is a function of space...
    created10 hours ago
  • Electrohydroconvection Engine?
    created12 hours ago
  • Question about entropy=0 in an irreversible process
    created12 hours ago
  • Question about Firing tank shell in freefall
    created14 hours ago
  • More from Physics Forums - Classical Physics

More news stories

Scientists discover likely new trigger for epidemic of metabolic syndrome

UC Davis scientists have uncovered a key suspect in the destructive inflammation that underlies heart disease and diabetes. The new research shows elevated levels of a receptor present on leucocytes of the innate immune response ...

Diabetes created 11 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Prediabetes may not explain diabetic polyneuropathies

In a reversal of two decades of medical reports, a Mayo Clinic study finds the frequency of nerve damage called diabetic polyneuropathy is similar in prediabetic patients and healthy people. Physicians should seek explanations ...

Diabetes created 18 hours ago | popularity not rated yet | comments 0

Study finds some insulin production in long-term Type 1 diabetes

Massachusetts General Hospital (MGH) research has found that insulin production may persist for decades after the onset of type 1 diabetes. Beta cell functioning also appears to be preserved in some patients years after apparent ...

Diabetes created Feb 21, 2012 | popularity not rated yet | comments 0 | with audio podcast

Revising the 'textbook' on liver metabolism offers new targets for diabetes drugs

A team led by researchers from the Institute for Diabetes, Obesity and Metabolism (IDOM) at the Perelman School of Medicine, University of Pennsylvania, has overturned a "textbook" view of what the body does after a meal. ...

Diabetes created Feb 21, 2012 | popularity not rated yet | comments 0

As diabetes emerges, researchers track disease's first steps

Scientists have taken a remarkably detailed look at the initial steps that occur in the body when type 1 diabetes mellitus first develops in a child or young adult.

Diabetes created Feb 16, 2012 | popularity 4.5 / 5 (2) | comments 0 | with audio podcast


Mini molecules could help fight battle of aortic bulge

When aortic walls buckle, the body's main blood pipe forms an ever-growing bulge. To thwart a deadly rupture, a team of Stanford University School of Medicine researchers has found two tiny molecules that may be able to orchestrate ...

Research links circadian rhythms to sudden cardiac death

A fundamental discovery reported in the March 1st issue of the journal Nature, uncovers the first molecular evidence linking the body's natural circadian rhythms to sudden cardiac death (SCD). Ventricular arrhythmias, or abn ...

Analysis of mTOR shows how the protein works, how new generation of drugs may defeat it

Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at the University of California, San Francisco (UCSF) have discovered ...

Phobia's effect on perception of feared object allows fear to persist

The more afraid a person is of a spider, the bigger that individual perceives the spider to be, new research suggests.

New melanoma drug Zelboraf nearly doubles survival in majority of patients

Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.

What can animals' survival instincts tell us about understanding human emotion?

Can animals' survival instincts shed additional light on what we know about human emotion? New York University neuroscientist Joseph LeDoux poses this question in outlining a pioneering theory, drawn from two decades of research, ...